Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 954, pseudogene (RNU6-954P) is a member of the U6 small nuclear RNA pseudogenes, located on chromosome 21 in humans[5]. This locus is a pseudogene, which means it is a non-functional genetic element derived from the U6 snRNA gene and does not encode a protein or functional snRNA[1][5]. U6 snRNA pseudogenes typically arise through retrotransposition mediated by long interspersed nuclear elements (LINEs, L1), and their presence serves as a marker for the evolutionary activity of retrotransposition in mammalian genomes[4]. Unlike canonical U6 snRNA, which is critical for the splicing of pre-mRNA, RNU6-954P does not contribute directly to RNA processing or cellular function. For most pseudogenes, including this one, there is no evidence supporting their status as therapeutic targets or biomarkers; their clinical or pharmacological relevance is generally limited unless specific regulatory functions are described, which is not the case for RNU6-954P[2][4].\n\nKey clarification:\n- Although some pseudogenes can affect gene regulation, there is no evidence that RNU6-954P itself acts as a therapeutic target, marker, or molecular regulator. Most references list it as a non-functional genetic element. Its nomenclature and listing are correct[1][3][5], but unless further research demonstrates a biological function or disease link for this specific pseudogene, it should not be considered a therapeutic target.\n\nSummary:\nRNU6-954P is best described as a small nuclear RNA pseudogene and is not a therapeutic target; it does not encode a functional molecule and has no known role in disease or pharmacology[1][5]. If structured data extraction for clinical, pharmacological, or regulatory annotation is intended, this entry should be flagged as non-target and missing actionable information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 954, pseudogene (RNU6-954P).